Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.770
+0.070 (4.12%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Metagenomi Employees
Metagenomi had 202 employees as of December 31, 2024. The number of employees decreased by 34 or -14.41% compared to the previous year.
Employees
202
Change (1Y)
-34
Growth (1Y)
-14.41%
Revenue / Employee
$258,886
Profits / Employee
-$386,426
Market Cap
66.17M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 202 | -34 | -14.41% |
Dec 31, 2023 | 236 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
MGX News
- 5 weeks ago - Metagenomi Reports Business Updates and Full Year 2024 Financial Results - GlobeNewsWire
- 6 weeks ago - Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems - GlobeNewsWire
- 2 months ago - Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference - GlobeNewsWire
- 3 months ago - Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones - GlobeNewsWire
- 3 months ago - Metagenomi Announces New Appointment to its Board of Directors - GlobeNewsWire
- 3 months ago - Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV” - GlobeNewsWire
- 4 months ago - Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting - GlobeNewsWire